Related Experiment Video
Updated: May 1, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Congenital heart disease linked to maternal autoimmunity against cardiac myosin
Charles R Cole1, Katherine E Yutzey, Anoop K Brar
1Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229;
Insights
This study introduces a novel autoimmune model for congenital heart disease (CHD), specifically hypoplastic left heart syndrome (HLHS). It suggests maternal autoantibodies against cardiac myosin may cause prenatal HLHS in fetuses.
Area of Science:
- Immunology
- Cardiology
- Developmental Biology
Background:
- Structural congenital heart disease (CHD) lacks established links to autoimmunity.
- Hypoplastic left heart syndrome (HLHS) is a severe left ventricular defect with unknown pathogenesis.
- Cardiac myosin (CM) is a known autoantigen in autoimmune heart conditions.
Purpose of the Study:
- To develop an autoimmune model of structural CHD resembling HLHS.
- To investigate the role of maternal autoantibodies against CM in prenatal HLHS development.
- To explore potential immune-mediated mechanisms in HLHS pathogenesis.
Main Methods:
- Developed a maternal-fetal autoimmune model of CHD using CM immunization.
- Assessed maternal and fetal serum autoantibody titers (anti-CM, anti-β-adrenergic receptor).
- Examined IgG reactivity in fetal myocardium and cardiac protein kinase A activity.
Main Results:
- Maternal immunization with CM induced anti-CM autoantibodies that crossed the placenta.
- Elevated maternal and fetal anti-CM autoantibodies correlated with structural CHD and diminished left ventricular dimensions.
- Fetuses with HLHS phenotype showed increased anti-β-adrenergic receptor Abs and protein kinase A activity.
Conclusions:
- Presents the first evidence of an immune-mediated mechanism for structural CHD pathogenesis, specifically HLHS.
- Suggests autoimmunity against CM may play a role in HLHS development via transplacental autoantibody transfer.
- Highlights potential implications for future diagnosis and treatment of HLHS through an immune-mediated lens.
Abstract:
Structural congenital heart disease (CHD) has not previously been linked to autoimmunity. In our study, we developed an autoimmune model of structural CHD that resembles hypoplastic left heart syndrome (HLHS), a life-threatening CHD primarily affecting the left ventricle. Because cardiac myosin (CM) is a dominant autoantigen in autoimmune heart disease, we hypothesized that immunization with CM might lead to transplacental passage of maternal autoantibodies and a prenatal HLHS phenotype in exposed fetuses. Elevated anti-CM autoantibodies in maternal and fetal sera, as well as IgG reactivity in fetal myocardium, were correlated with structural CHD that included diminished left ventricular cavity dimensions in the affected progeny. Further, fetuses that developed a marked HLHS phenotype had elevated serum titers of anti-β-adrenergic receptor Abs, as well as increased protein kinase A activity, suggesting a potential mechanism for the observed pathological changes. Our maternal-fetal model presents a new concept linking autoimmunity against CM and cardiomyocyte proliferation with cardinal features of HLHS. To our knowledge, this report shows the first evidence in support of a novel immune-mediated mechanism for pathogenesis of structural CHD that may have implications in its future diagnosis and treatment.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myasthenia Gravis ll: Pathophysiology
Cardiomyopathy I: Introduction and Classification

